Works by Townley, Scott


Results: 8
    1
    2

    Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

    Published in:
    2024
    By:
    • Rahman, Razia;
    • Rahaman, Muhammed H.;
    • Hanson, Adrienne R.;
    • Choo, Nicholas;
    • Xie, Jianling;
    • Townley, Scott L.;
    • Shrestha, Raj;
    • Hassankhani, Ramin;
    • Islam, Saiful;
    • Ramm, Susanne;
    • Simpson, Kaylene J.;
    • Risbridger, Gail P.;
    • Best, Giles;
    • Centenera, Margaret M.;
    • Balk, Steven P.;
    • Kichenadasse, Ganessan;
    • Taylor, Renea A.;
    • Butler, Lisa M.;
    • Tilley, Wayne D.;
    • Conn, Simon J.
    Publication type:
    Correction Notice
    3

    CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 6, p. 1092, doi. 10.1038/s41416-024-02810-8
    By:
    • Rahman, Razia;
    • Rahaman, Muhammed H.;
    • Hanson, Adrienne R.;
    • Choo, Nicholas;
    • Xie, Jianling;
    • Townley, Scott L.;
    • Shrestha, Raj;
    • Hassankhani, Ramin;
    • Islam, Saiful;
    • Ramm, Susanne;
    • Simpson, Kaylene J.;
    • Risbridger, Gail P.;
    • Best, Giles;
    • Centenera, Margaret M.;
    • Balk, Steven P.;
    • Kichenadasse, Ganessan;
    • Taylor, Renea A.;
    • Butler, Lisa M.;
    • Tilley, Wayne D.;
    • Conn, Simon J.
    Publication type:
    Article
    4

    FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49234-9
    By:
    • Wang, Zifeng;
    • Townley, Scott L.;
    • Zhang, Songqi;
    • Liu, Mingyu;
    • Li, Muqing;
    • Labaf, Maryam;
    • Patalano, Susan;
    • Venkataramani, Kavita;
    • Siegfried, Kellee R.;
    • Macoska, Jill A.;
    • Han, Dong;
    • Gao, Shuai;
    • Risbridger, Gail P.;
    • Taylor, Renea A.;
    • Lawrence, Mitchell G.;
    • He, Housheng Hansen;
    • Selth, Luke A.;
    • Cai, Changmeng
    Publication type:
    Article
    5

    SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control.

    Published in:
    Science Translational Medicine, 2020, v. 12, n. 559, p. 1, doi. 10.1126/scitranslmed.aaz8048
    By:
    • Montgomery, Magdalene K.;
    • Bayliss, Jacqueline;
    • Devereux, Camille;
    • Bezawork-Geleta, Ayenachew;
    • Roberts, David;
    • Huang, Cheng;
    • Schittenhelm, Ralf B.;
    • Ryan, Andrew;
    • Townley, Scott L.;
    • Selth, Luke A.;
    • Biden, Trevor J.;
    • Steinberg, Gregory R.;
    • Samocha-Bonet, Dorit;
    • Meex, Ruth C. R.;
    • Watt, Matthew J.
    Publication type:
    Article
    6
    7
    8